Smith Group Asset Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-3,460
Closed -$290K – 461
2019
Q1
$290K Sell
3,460
-11,520
-77% -$1.2M 0.01% 202
2018
Q4
$1.76M Buy
14,980
+6,380
+74% +$738K 0.06% 140
2018
Q3
$1.04M Buy
+8,600
New +$1.07M 0.03% 170
2016
Q1
– Sell
-36,340
Closed -$2.32M – 526
2015
Q4
$2.32M Sell
36,340
-6,020
-14% -$390K 0.07% 136
2015
Q3
$2.84M Buy
42,360
+28,720
+211% +$2.03M 0.11% 127
2015
Q2
$932K Buy
13,640
+380
+3% +$24.1K 0.03% 171
2015
Q1
$737K Sell
13,260
-1,000
-7% -$51.3K 0.02% 187
2014
Q4
$731K Buy
+14,260
New +$700K 0.03% 193
2014
Q2
– Sell
-109,388
Closed -$4.12M – 447
2014
Q1
$4.12M Buy
109,388
+108,890
+21,865% +$3.8M 0.16% 114
2013
Q4
$18K Sell
498
-69,726
-99% -$2.67M ﹤0.01% 286
2013
Q3
$3.05M Sell
70,224
-7,242
-9% -$291K 0.13% 134
2013
Q2
$2.8M Buy
+77,466
New +$2.35M 0.12% 144

Other funds holding USNA

Smith Group Asset Management's USNA Position: Q2 2019 in Review

Smith Group Asset Management sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 3,460 shares — an estimated $290K sold.

Smith Group Asset Management first reported a position in USNA in Q2 2013 and held it in 12 quarters. The position peaked at $4.12M in Q1 2014. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

  • Smith Group Asset Management reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
  • Smith Group Asset Management sold 3,460 Usana Health Sciences shares in Q2 2019, an estimated $290K.
  • Smith Group Asset Management first reported a position in Usana Health Sciences in Q2 2013 and held it in 12 quarters.
  • Smith Group Asset Management's Usana Health Sciences position peaked at $4.12M in Q1 2014.
  • 173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on Smith Group Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.